Current perspectives on the therapeutic utility of VR1 antagonists
about
A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicinPharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in miceEndogenous cannabinoids induce fever through the activation of CB1 receptorsAnandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptorsOld molecules for new receptors: Trp(Nps) dipeptide derivatives as vanilloid TRPV1 channel blockers.Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia.Neonatal capsaicin treatment in rats induces chronic hyperthermia resulting in infectious disease.Nutrition management of chronic diarrhea and malabsorption.Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?ThermoTRP channels in nociceptors: taking a lead from capsaicin receptor TRPV1Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in ratsPlatelet-rich plasma and the elimination of neuropathic pain.In silico research to assist the investigation of carboxamide derivatives as potent TRPV1 antagonists.Capsazepine concentration dependently inhibits currents in HEK 293 cells mediated by human hyperpolarization-activated cyclic nucleotide-gated 2 and 4 channels.[The capsaicin receptor. "TRPing" transduction for painful stimuli].
P2860
Q26859032-40DE66D6-8E8B-4D10-91FD-097DFFD38E57Q28477318-F769A164-C6B1-4FB4-ABA2-D2A26491DB38Q28572642-50596393-96EB-49D1-9A51-13DC0517C8D7Q28581593-CC723722-36FD-4746-96A6-4847B25667E8Q31051986-8160D5DF-DB38-4433-A5BF-B8EC6C5674EFQ35049206-F6847F65-4793-45A4-B169-090540C8898CQ36336358-77E2C069-2079-4C66-85C9-48A3965FD3B4Q36378740-8AF16BF6-D331-431C-BC05-887B0B62D304Q36506375-32492366-7628-4A99-AF00-38A1E35190A0Q37104144-6B262EA6-88B7-412C-A271-549F48C616BBQ37224649-E74F2BCE-D4A0-42E5-AC94-FA739616CD90Q38119874-81B0C9DC-1352-4BEB-AA3D-D0DBEC6253FEQ38977003-58EA2424-0589-43AC-813F-37E150AA2408Q45386818-E5BB98B8-DFFF-4683-80F2-E739A19E8D76Q46694092-EBB1E073-DADC-4F63-B3A5-5C697385756E
P2860
Current perspectives on the therapeutic utility of VR1 antagonists
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Current perspectives on the therapeutic utility of VR1 antagonists
@ast
Current perspectives on the therapeutic utility of VR1 antagonists
@en
Current perspectives on the therapeutic utility of VR1 antagonists
@nl
type
label
Current perspectives on the therapeutic utility of VR1 antagonists
@ast
Current perspectives on the therapeutic utility of VR1 antagonists
@en
Current perspectives on the therapeutic utility of VR1 antagonists
@nl
prefLabel
Current perspectives on the therapeutic utility of VR1 antagonists
@ast
Current perspectives on the therapeutic utility of VR1 antagonists
@en
Current perspectives on the therapeutic utility of VR1 antagonists
@nl
P356
P1476
Current perspectives on the therapeutic utility of VR1 antagonists
@en
P2093
P304
P356
10.2174/0929867043363686
P407
P577
2004-12-01T00:00:00Z